758 results on '"Chapman, Joab"'
Search Results
102. Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms
103. Inhibition of Ras attenuates the course of experimental autoimmune neuritis
104. Hidden function of neuronal nicotinic acetylcholine receptor β2 subunits in ganglionic transmission: comparison to α5 and β4 subunits
105. Vasculitides—Miscellaneous Vasculitides
106. Rheumatoid Arthritis: Peripheral and Central Nervous System Involvement
107. MEDIAL PLANTAR NERVE TESTING FACILITATES IDENTIFICATION OF POLYNEUROPATHY
108. Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block
109. Identification of Histidine-Rich Glycoprotein, a Potential Autoantigen, in Human and Rat Brain Preparations
110. Induction of autoimmune depression in mice by anti–ribosomal P antibodies via the limbic system
111. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome
112. The role of the APOE genotype in immunomodulation
113. The interface of multiple sclerosis and antiphospholipid antibodies
114. Nicotinic acetylcholine receptor α5 subunits modulate oxotremorine-induced salivation and tremor
115. Immunization with cholinergic cell bodies induces histopathological changes in rat brains
116. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice
117. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome
118. Increased Leukocyte Aggregation Induced by γ-Globulin: A Clue to the Presence of Pseudoleukopenia
119. Increased brain plasmin levels following experimental ischemic stroke in male mice.
120. Preliminary Observations on APOE ε4 Allele and Progression of Disability in Multiple Sclerosis
121. A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis
122. The role of thrombin in the pathogenesis of diabetic neuropathy
123. Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Relapsing Remitting Multiple Sclerosis: Safety, Tolerability and Efficacy (No Evidence of Disease Activity) Two-Years Analysis (P3.2-052)
124. The impact of self-replicating proteins on inflammation, autoimmunity and neurodegeneration—An untraveled path
125. Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis
126. Pros and cons of a prion-like pathogenesis in Parkinson's disease
127. A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma
128. Disease duration in E200K familial Creutzfeldt–Jakob disease is correlated with clinical, radiological, and laboratory variables
129. ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer's Dementia
130. Retraction: Familial Alzheimer's disease associated with S182 codon 286 mutation
131. Familial Alzheimer's disease associated with S182 codon 286 mutation
132. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
133. INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation
134. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
135. Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment
136. Apixaban decreases brain thrombin activity in a male mouse model of acute ischemic stroke
137. Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.359)
138. Local Regulation of Thrombin Activity by Factor Xa in Peripheral Nerve Schwann Cells
139. Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?
140. Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus
141. In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke
142. A Linear Temporal Increase in Thrombin Activity and Loss of Its Receptor in Mouse Brain following Ischemic Stroke
143. Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)
144. Restoring GM1 ganglioside expression ameliorates axonal outgrowth inhibition and cognitive impairments induced by blast traumatic brain injury
145. Thrombin and protein C pathway in peripheral nerve Schwann cells
146. CSF tau correlates with the degree of cortical involvement in E200K familial Creutzfeldt-Jakob disease
147. Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes
148. Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development
149. The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro
150. Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.